Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials

David L Wirta1 Aesthetic Eye Care Institute & Eye Research Foundation, Newport Beach, CA, USACorrespondence[email protected]

Michael S Korenfeld2 Comprehensive Eye Care, Ltd., Washington, MO, USA

Shane Foster3 Athens Eye Care, Athens, OH, USA

Robert Smyth-Medina4 North Valley Eye Medical Group, Mission Hills, CA, USA

Jason Bacharach5 North Bay Eye Associates, Petaluma, CA, USA

Shane R Kannarr6 Kannarr Eye Care, Pittsburg, KS, USA

Mark J Jaros7 Summit Analytical, Denver, CO, USA

Charles B Slonim8 Department of Ophthalmology, University of South Florida Morsani College of Medicine, Tampa, FL, USA

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.